DOI:
10.1055/s-00000142
Frauenheilkunde up2date
LinksClose Window
References
Mutch DG, Orlando M, Goss T. et al.
Randomized phase III trial of gemcitabine compared with pegylated liposomal doxorubicin in patients with platinum-resistant ovarian cancer.
J Clin Oncol 2007;
25: 2811-2818
We do not assume any responsibility for the contents of the web pages of other providers.